Ain Holdings Inc.
Notice Regarding Group Restructuring (Absorption-type Company Split and Absorption-type Merger Between Consolidated Subsidiaries)
On May 1, 2026, an absorption-type company split and absorption-type merger will be conducted between consolidated subsidiaries to mutually succeed part of the pharmacy business, and Sakura Pharmacy Co., Ltd. will be absorbed by Kraft Co., Ltd.
Key Figures
- Absorption-type Company Split ① Net Sales (Divided Business Segment): 10,426 million yen
- Absorption-type Company Split ② Net Sales (Divided Business Segment): 5,500 million yen
- Sakura Pharmacy Net Sales: 35,082 million yen
AI要約
Overview of Group Restructuring
AIN HOLDINGS INC. will execute an absorption-type company split and absorption-type merger between consolidated subsidiaries effective May 1, 2026. Specifically, Ain Pharmacies will transfer part of its pharmacy operations in the Chugoku region to Pharmacy, and Pharmacy will transfer part of its pharmacy operations in the Kansai and Shikoku regions to Ain Pharmacies in a reciprocal absorption-type company split. Additionally, Sakura Pharmacy Co., Ltd. will be dissolved through an absorption-type merger with Kraft Co., Ltd. as the surviving company. These restructurings are conducted among wholly owned subsidiaries and involve no allocation of shares or provision of consideration.
Purpose of Restructuring and Future Outlook
This intra-group restructuring aims to improve operational efficiency of pharmacy management and reduce redundant administrative tasks, thereby enhancing the overall business efficiency of the group. Since the restructuring is among wholly owned subsidiaries, the impact on financial results is expected to be minimal. Changes in representatives are planned for some subsidiaries, and there will be no changes to company name, business content, capital, or fiscal year-end after the restructuring.
